Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-22
2009-02-10
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S309000, C546S126000, C546S183000
Reexamination Certificate
active
07488737
ABSTRACT:
The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nACh receptors), activation of nACh receptors, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds (indazoles and benzothiazoles), which act as ligands for the α7 nACh receptor subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
REFERENCES:
patent: 4605652 (1986-08-01), Welstead et al.
patent: 4775668 (1988-10-01), Jefson et al.
patent: 4789673 (1988-12-01), Donatsch et al.
patent: 4798829 (1989-01-01), King et al.
patent: 4845092 (1989-07-01), Sanger et al.
patent: 4886808 (1989-12-01), King
patent: 4895943 (1990-01-01), Friedmann
patent: 4910193 (1990-03-01), Buchheit
patent: 4910207 (1990-03-01), Donatsch et al.
patent: 4937247 (1990-06-01), King
patent: 4942160 (1990-07-01), Sanger et al.
patent: 4975436 (1990-12-01), Tyers
patent: 4985424 (1991-01-01), van Wijngaarden et al.
patent: 5017582 (1991-05-01), Donatsch
patent: 5034398 (1991-07-01), King
patent: 5063231 (1991-11-01), Sanger et al.
patent: 5098889 (1992-03-01), Costall et al.
patent: 5098909 (1992-03-01), Williams
patent: 5192770 (1993-03-01), Clark et al.
patent: 5204356 (1993-04-01), Tyers
patent: 5223625 (1993-06-01), van Wijingaarden et al.
patent: 5272154 (1993-12-01), Dixon et al.
patent: 5273972 (1993-12-01), Jagdmann et al.
patent: 5446050 (1995-08-01), Rosen
patent: 5543426 (1996-08-01), Dixon et al.
patent: 5561149 (1996-10-01), Azria et al.
patent: 5641802 (1997-06-01), Arcamone et al.
patent: 5679673 (1997-10-01), Bowen et al.
patent: 5773436 (1998-06-01), Muller et al.
patent: 5985866 (1999-11-01), Muller et al.
patent: 6492385 (2002-12-01), Myers et al.
patent: 6500840 (2002-12-01), Myers et al.
patent: 6599916 (2003-07-01), Myers et al.
patent: 6624173 (2003-09-01), Crooks et al.
patent: 6780861 (2004-08-01), Nozulak
patent: 6828330 (2004-12-01), Walker et al.
patent: 6849620 (2005-02-01), Walker et al.
patent: 6911543 (2005-06-01), Walker et al.
patent: 7001900 (2006-02-01), Jacobsen et al.
patent: 2002/0086871 (2002-07-01), O'Neill et al.
patent: 2002/0119972 (2002-08-01), Leftheris et al.
patent: 2003/0073707 (2003-04-01), Walker et al.
patent: 2004/0002513 (2004-01-01), Mazurov et al.
patent: 2005/0182062 (2005-08-01), Sanofi
patent: 2005/0209236 (2005-09-01), Hendrix et al.
patent: 2006/0014750 (2006-01-01), O'Donnell et al.
patent: 2 361 437 (1988-03-01), None
patent: 10 305 922 (2004-03-01), None
patent: 0013138 (1980-07-01), None
patent: 0 200 444 (1986-11-01), None
patent: 0 214 772 (1987-03-01), None
patent: 0 279 512 (1988-08-01), None
patent: 0 377 238 (1990-07-01), None
patent: 0 498 466 (1992-08-01), None
patent: 1 079 828 (2001-03-01), None
patent: 1 219 622 (2002-07-01), None
patent: 1 235 826 (2002-09-01), None
patent: 0 261 964 (2008-08-01), None
patent: 2 548 666 (1985-01-01), None
patent: 2 845 388 (2004-04-01), None
patent: 2 125 398 (1984-03-01), None
patent: 2 145 416 (1985-03-01), None
patent: 2002-30084 (2002-01-01), None
patent: WO 84/00166 (1984-01-01), None
patent: WO 85/01048 (1985-03-01), None
patent: WO 90/14347 (1990-11-01), None
patent: WO 91/09593 (1991-07-01), None
patent: WO 92/12149 (1992-07-01), None
patent: WO 93/08185 (1993-04-01), None
patent: WO 97/30998 (1997-08-01), None
patent: WO 00/44755 (2000-08-01), None
patent: WO 00/58311 (2000-10-01), None
patent: WO 01/58869 (2001-08-01), None
patent: WO 01/90109 (2001-11-01), None
patent: WO 01/92260 (2001-12-01), None
patent: WO 02/17358 (2002-02-01), None
patent: WO 02/36114 (2002-05-01), None
patent: WO 02/085901 (2002-10-01), None
patent: WO 00/45846 (2002-12-01), None
patent: WO 02/096911 (2002-12-01), None
patent: WO 02/100833 (2002-12-01), None
patent: WO 02/100857 (2002-12-01), None
patent: WO 02/100858 (2002-12-01), None
patent: WO 03/022856 (2003-03-01), None
patent: WO 03/029252 (2003-04-01), None
patent: WO 03/037806 (2003-05-01), None
patent: WO 03/037896 (2003-05-01), None
patent: WO 03/042210 (2003-05-01), None
patent: WO 03/051874 (2003-06-01), None
patent: WO 03/070731 (2003-08-01), None
patent: WO 03/072578 (2003-09-01), None
patent: WO 03/078431 (2003-09-01), None
patent: WO 03/080606 (2003-10-01), None
patent: WO 03/094830 (2003-11-01), None
patent: WO 03/101987 (2003-11-01), None
patent: WO 2004/013137 (2004-02-01), None
patent: WO 2004/014864 (2004-02-01), None
patent: WO 2004/014922 (2004-02-01), None
patent: WO 2004/016617 (2004-02-01), None
patent: WO 2004016616 (2004-02-01), None
patent: WO 2004/029050 (2004-04-01), None
patent: WO 2004/033456 (2004-04-01), None
patent: WO 2005/001299 (2005-02-01), None
Fludzinski et al., Journal of Medicinal Chemistry, 1987, vol. 30, pp. 1535-1537.
Bermudez et al., Journal of Medicinal Chemistry, 1990, vol. 33, pp. 1924-1929.
Robertson et al., Journal of Medicinal Chemistry, 1990, vol. 33, pp. 3176-3181.
Schmidt et al., Molecular Pharmacology, 1990, vol. 38, pp. 511-516.
Robertson et al., Journal of Medicinal Chemistry, 1992, vol. 35, pp. 310-319.
Schaus et al., Journal of Medicinal Chemistry, 1998, vol. 41, pp. 1943-1955.
Int'l. Search Report and the Written Opinion of the Int'l. Searching Authority, issued Nov. 24, 2005 in PCT/US2005/013938.
Sakaguchi et al. Chem Phar Bull., 2001, 49(4) 424-436.
Bermudez et al., J. Med. Chem., 1990, 33, 1924-1929.
Nurhrich et al., Eur. J. Med. Chem., 1996, No. 31, pp. 957-964.
Schaus et al., J. Med. Chem., 1998, No. 41, pp. 1943-1955.
Robertson et al., J. Med. Chem., 1990, No. 33, pp. 3176-3181.
Macor et al., Bioorganic & Medicinal Chem. Letters 11, 2001, pp. 319-321.
Toledana, et al., Journal of Molecular Structure 406, 1997, pp. 223-232.
Romanelli et al., Arzneim-Forsch/Drug Res. 43 (II) Nr. 8 1993, pp. 913-918.
S.M. Evans et al., “Probing the 5-HT3Receptor Site Using Novel Indole-3-Glyoxylic Acid Derivatives”, Med. Chem. Res. (1993), 3:386-406.
D. Flammia, “Lobeline: Structure-Affinity Investigation of Nicotinic Acetylcholinergic Receptor Binding”, J. Med. Chem. (1999), 42:3726-2731.
R. Azuma et al. “Metabolism and Disposition of GTS-21, A Novel Drug for Alzheimer's Disease”, Xenobiotica (1999), vol. 29, No. 7, pp. 747-762.
K. E. Stevens. et al., “Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice”, Psychopharmacology (1998), 136:320-327.
R. Azuma et al., “The effect of repeat administration of GTS-21 on mixed-function oxidase activities in rat”, Elsevier Science Ireland Ltd., Toxicology Letters 110 (1999) pp. 137-144.
M. Decker, et al., “Neuronal Nicotinic Acetylcholine Receptors: Novel Targets for CNS Therapeutics”, 2000, pp. 1-14.
M. W. Holladay et al., “Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery”, Journal of Medicinal Chemistry, vol. 40, No. 26, (1997), pp. 4169-4194.
Astles et al., Current Drug Targets—CNS Neurological Disorders, 2002, 1, pp. 337-348.
Mazurov et al., Biorg. & Med. Chem. Lett., 2005, No. 1 15, pp. 2073-2077.
Nurhrich et al., Eur. J. Med. Chem. 1996, No. 31, pp. 957-964.
Bermudez et al., J. Med. Chem., 1990, 33,1924-1929.
Gauss Carla Maria
Herbert Brian
Ma Jianguo
Nguyen Truc Minh
Schumacher Richard
Memory Pharmaceutical Corporation
Millen White Zelano & Branigan P.C.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Indoles, 1H-indazoles, 1,2-benzisoxazoles,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoles, 1H-indazoles, 1,2-benzisoxazoles,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoles, 1H-indazoles, 1,2-benzisoxazoles,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4102233